Zurueck zur Suche

Reporte zur Charge U016064

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 1 MO 1 MI 1 IN 1 GA 1 NJ 1 NY 1 SC 1

VAERS 2092540

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

schwer
Staat
TX
Alter
18,0
Geschlecht
M
Eingang
07.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Syncope

Symptomtext

SYNCOPE, witnessed loss of consciousness no more than 30 seconds

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA Allergic to Shellfish
Vorherige Impfungen
-

VAERS 2588101

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

mild
Staat
MO
Alter
24,0
Geschlecht
F
Eingang
28.02.2023
Impfdatum
13.01.2023
Beginn
13.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Exposure during pregnancy Incomplete course of vaccination Injection site erythema Injection site pruritus Injection site reaction Injection site warmth Ultrasound antenatal screen normal

Symptomtext

injection site reaction after her first dose which was red, warm, and itchy; injection site reaction after her first dose which was red, warm, and itchy; injection site reaction after her first dose which was red, warm, and itchy; Inbound call from HCP who stated a pregnant patient came in for their second dose of VARIVAX where it was determined she was pregnant and did not receive her second dose. Patient had stated she had an injection site reaction after her first dose whic; This spontaneous prospective pregnancy report was received from a nurse, and refers to a 24-year-old female patient. No information was reported regarding the patient's medical history, concurrent conditions or concomitant medications. On 13-JAN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) at a dose of 0.5ml, lot U016064, expiration date 20-MAY-2023 (route of administration was not reported) as prophylaxis, which was diluted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were unknown). The patient stated that on 13-JAN-2023, after the first dose, she experienced an injection site reaction after her first dose which was red, warm, and itchy but spontaneously resolved on an unspecified date in 2023 (reported as "a few days after she received the injection"). The patient had an ultrasound on an unspecified date in 2023 (reported as "since the first dose") which determined "everything was fine". On an unspecified date in 2023, the patient came in for their second dose of varicella virus vaccine live (oka/merck)(VARIVAX) where it was determined she was pregnant and did not receive her second dose. The patient became pregnant with last menstrual period of 15-AUG-2022. Estimated date of delivery was 22-MAY-2023. Initial exposure to varicella virus vaccine live (oka/merck)(VARIVAX) was at 21 weeks. The pregnancy outcome was outcome pending. Causality assessment was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Medication dilution
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2528343

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

mild
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
09.12.2022
Impfdatum
21.10.2021
Beginn
22.10.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Urticaria

Symptomtext

Pt. had redness around the nape of her neck and her ears earlier the morning following the vaccinations. No other symptoms at that time, 6 hours later I have noticed hives. A few on her neck and some on her lower back. I gave her Benadryl at 8:30 Friday ( day after vaccine) night and she was rash free the next morning but then around 3:30pm it came back and it was odd because it was red almost opposite of where it was red the day before. It appeared to me to look like a chemical burn from the inside out. I would like to share photos if able.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2401030

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
04.08.2022
Impfdatum
18.07.2022
Beginn
18.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event Wrong product administered

Symptomtext

PROQUAD was inadvertently administered with VARIVAX; No additional Adverse Event (AE) details; PROQUAD was inadvertently administered with VARIVAX instead of MMR-II; This spontaneous report was received from a health professional referring to an unknown age and gender patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported. On 18-JUL-2022, the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection, lot number W004028, expiration date: 02-AUG-2023 was inadvertently administered with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot number U016064, expiration date: 20-MAY-2023, and sterile diluent, solution for injection/infusion, lot number W000443 which was determined to be valid with expiration date: 20-APR-2024, instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection; all vaccines were administered subcutaneously for prophylaxis (strength, dose and anatomical site were not provided) (wrong product administered) (accidental overdose). No additional adverse event (AE) information was provided (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2334795

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

gering
Staat
GA
Alter
2,0
Geschlecht
U
Eingang
25.06.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

No additional AE; 2 year old was concomitantly administered PROQUAD and VARIVAX; This spontaneous report was received from a nurse practitioner referring to a 2-year-old patient of unknown gender. The patient's concomitant medications, concurrent conditions, medical history and drug reactions/allergies were not reported. On 23-MAY-2022, the patient was concomitantly administered with 1 dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (strength and route not reported, lot # U029150, expiration date: 16-MAR-2023, therapy type: rHA) and 1 dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength and route not reported, lot # U016064, expiration date: 20-MAY-2023) for prophylaxis (overdose). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2272996

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
12.05.2022
Impfdatum
18.03.2022
Beginn
18.04.2022
Tage bis Beginn
31,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Caller is an office manager who reports administration of vaccine following temperature excursion. No adverse effects of administration. No further information provided. No other AE/no PQC. ? Names of vaccines involved (including lot/exp; Caller is an office manager who reports administration of vaccine following temperature excursion. No adverse effects of administration. No further information provided. No other AE/no PQC. ? Names of vaccines involved (including lot/exp; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 18-APR-2022, the patient was vaccinated with an improper storage dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5ml/once, with valid lot #U016064, expiration date: 20-MAY-2023 (strength, route of administration, and indication were not provided); and with sterile diluent (DILUENT MRK) (strength, formulation, dose description, lot #, expiry date, route of administration, and indication were not provided). Temperature was 14.5 degree Celsius (C) time frame of 10 hours, there was not previous temperature excursion. No adverse effects after administration. No further information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2098041

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
09.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Underdose

Symptomtext

no additional adverse events reported; she did not screw the needle on the syringe good enogh and of the vaccine spraying out of the patient, only partial dose was delivered; This spontaneous report has been received from Licensed practical nurse concerning to 5-year-old unknown gender patient. The patient's current conditions, medical history and historical drug were not reported. No concomitant therapies were provided. On 01-FEB-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, (lot #U016064 and expiration date since it makes match with the autopopulated expiration date 20-MAY-2023) (strength, route of administration, and indication were not provided). It was reported that while was prepping a dose of virus vaccine live (oka/merck) (VARIVAX), the nurse did not screw the needle on the syringe good enough and when was administered the vaccine to the patient, only a partial dose (unknown amount) was delivered due to some of the vaccine spraying out of the hub where the needle attaches (underdose). No additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1838623

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016064

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
03.11.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Needle issue No adverse event

Symptomtext

No additional AEs reported; She reported that 0.1ml of VARlVAX was left in the syringe that the patient did not receive; This spontaneous report was received from a nurse and refers to a child patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 20-OCT-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # U016064, expiration date not provided but after internal validation determined as 20-MAY-2023 (dose, route of administration and anatomical location were not provided) for prophylaxis. During vaccination, the patient jumped, and the needle came out during the injection. Reporter stated that 0.1 mL of varicella virus vaccine live (Oka/Merck) (VARIVAX) was left in the syringe that the patient did not received (incomplete dose administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-